过去一年中添加的文章,按日期排序

Repurposing Kinase Inhibitors for COVID-19 A Comprehensive Review of Antiviral and Immunomodulatory Effects

R Bhat, G Palakki, M Uday, V Karicheri… - International Journal of …, 2024 - ijphi.com
5 天前 - pathways involved … therapeutic landscape of kinase inhibitors in COVID-19. Notably,
the FDA has approved Baricitinib in combination with remdesivir for hospitalized COVID-19

Soluble platelet selectin and platelets in COVID-19: a multifaceted connection

EI Obeagu, GU Obeagu, PM Aja… - Annals of Medicine …, 2024 - journals.lww.com
5 天前 - … agents, platelet inhibitors, and anti-inflammatory therapies … of effective therapeutic
strategies for managing COVID-19-… therapeutic strategies targeting sP-selectin pathways, …

Synthesis and Characterization of DHODH Inhibitors Based on the Vidofludimus Scaffold with Pronounced Anti‐SARS‐CoV‐2 Activity

C Gege, F Hahn, C Wangen, S Häge, A Herrmann… - ChemMedChem - Wiley Online Library
6 天前 - coronavirus 2 (SARS-CoV-2). Host-directed antivirals that target universal cellular
metabolic pathways … ) (Table 1), treatment of COVID-19 patients with 45 mg VidoCa 1 …

Green synthesis of medicine and development of inhibitors for druggable proteins of SARS-COV-2

Q Chen - 2024 - theses.lib.polyu.edu.hk
8 天前 - COVID-19. We further renamed the compound as SHEN 26, and we went on to
optimize its synthetic route … oral anti-coronavirus drugs for clinical treatment of COVID-19 and for …

Investigating Herpesvirus Replication and Virus-Host Interactions During SARS-CoV-2 Co-infections

SL Payen - 2024 - scholarworks.unr.edu
11 天前 - … in a dominant-negative inhibition of virus replication, … receptor interactions and
inflammatory pathways in HCMV-… therapeutic interventions for severe cases of COVID-19 among …

[HTML][HTML] Effect of JAK Inhibitors on the Risk of Death in Patients with Moderate to Severe COVID-19: A Systematic Review and Meta-Analysis of Randomized …

CS Kow, DS Ramachandram… - Canadian Journal of …, 2024 - cjhp-online.ca
12 天前 - … of COVID-19 involves a signalling pathway based on the … effective treatments in the
ongoing COVID-19 pandemic by … of other JAK inhibitors in the treatment of COVID-19 and to …

Activation of Alveolar Epithelial ER Stress by β-Coronavirus Infection Disrupt Surfactant Homeostasis in Mice: Implications for Covid-19 Respiratory Failure

A Murthy, LR Rodriguez… - … of Physiology-Lung …, 2024 - journals.physiology.org
13 天前 - … attenuated by treatment with the IRE1α inhibitor OPK711. … multiple AT2 UPR stress
pathways, altering surfactant … potential role for replacement 399 therapy with COVID-19 (63). …

An Integrative Network Pharmacology and Bioinformatics Approach for Deciphering the Multi-target Effect of Nyctanthes arbortristis L. against COVID-19

N Sreeharsha, GM Basavarajappa… - Current … - pubmed.ncbi.nlm.nih.gov
14 天前 - … , and signaling pathways in Nyctanthes arbortristis for the treatment of COVID-19. In
the … through the enhancement of immunologic functions, inhibition of inflammatory reactions …

Targeting the Neuropilin-1 receptor with Ovatodiolide and progress in using periodontal ligament organoids for COVID-19 research and therapy

MS Hsieh, MY Chen, YS Chang, CS Huang, TN Hsu… - Life Sciences, 2024 - Elsevier
21 天前 - … The research uncovers various pathways and biochemical strategies through which
therapeutic role of Ovatodiolide (OVA) in this scenario. We found that OVA can inhibit the …

POS0081 ASSOCIATIONS OF CIRCULATING INFLAMMATORY CYTOKINES WITH LONG COVID AMONG PATIENTS WITH SYSTEMIC AUTOIMMUNE RHEUMATIC …

JA Sparks, X Wang, PY Lee, K Brodeur, M Lin, N Patel… - 2024 - ard.bmj.com
24 天前 - … for long COVID may be helpful to identify biologic pathways and develop treatments
and … , and 53 (26%) were on TNF inhibitors. A total of 54 (27%) cases were unvaccinated at …